HIV-associated nephropathy

Kidney International

Volumn 56, Issue 3, 1999, Pages 1161-1176

  Klotman, Paul E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; AIDS; Collapsing glomerulopathy; End stage renal failure; Focal segmental glomerulopathy; Microcystic tubulointerstitial disease

Indexed keywords

COTRIMOXAZOLE; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEROID THERAPY;

EID: 0032851614     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00748.x     Document Type: Article

References (86)

1. 1. Bourgoignie JJ: Renal complications of human immunodeficiency virus type 1. Kidney Int 37:1571-1584, 1990
2. 2. Bourgoignie JJ, Meneses R, Ortiz C, Jaffee D, Pardo V: The clinical spectrum of renal disease associated with immunodeficiency virus. Am J Kidney Dis 12:131-137, 1988
3. 3. Rao TK, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316:1062-1068, 1987
4. 4. Rao TK: Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 40(Suppl 35):S13-S18, 1991
5. 5. Rao TK: Acute renal failure syndromes in human immmunodeficiency virus infection. Semin Nephrol 18:378-395, 1998
6. 6. Kopp JB, Miller KD, Mican JA, Feuerstein IM, Vaughan E, Baker C, Pannell LK, Faloon J: Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 127:119-125, 1997
7. 7. Berns JS, Cohen RM, Silverman M, Turner J: Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases. Am J Kidney Dis 30:558-560, 1997
8. 8. Vittecoq D, Dumitrescu L, Beaufils H, Deray G: Fanconi syndrome associated with cidofovir therapy. (letter) Antimicrob Agents Chemother 41:1846, 1997
9. 9. Tashima KT, Horowitz JD, Rosen S: Indinavir nephropathy. (letter) N Engl J Med 336:138-140, 1997
10. 10. Chugh S, Bird R, Alexander EA: Ritonavir and renal failure. (letter) N Engl J Med 336:138, 1997
11. 11. Duong M, Sgro C, Grappin M, Biron F, Boibieux A: Renal failure after treatment with ritonavir. (letter) Lancet 348:693, 1996
12. 12. Gardenswartz MH, Lerner CW, Seligson GR, Zabetakis PM, Rotterdam H, Tapper ML, Michelis MF, Bruno MS: Renal disease in patients with AIDS: A clinicopathologic study. Clin Nephrol 21:197-204, 1984
13. 13. Soni A, Agarwal A, Chander P, Yoo J, Singal D, Salomon N, Robinson B, Treser G: Evidence for an HIV-related nephropathy: A clinicopathological study. Clin Nephrol 31:12-17, 1989
14. 14. Valeri A, Neusy AJ: Acute and chronic renal disease in hospitalizated AIDS patients. Clin Nephrol 35:110-118, 1991
15. 15. Appel GB, Nicolaides MN: Human immunodeficiency virus/acquired immunodeficiency syndrome nephropathy in the inner city. N Y State J Med 91:207-210, 1991
16. 16. Provenzano R, Kupin W, Santiago GC: Renal involvement in the acquired immunodeficiency syndrome: presentation, clinical course, and therapy. Henry Ford Hosp Med J 135:38-41, 1987
17. 17. Frassetto L, Schoenfeld P, Humphreys M: The increasing incidence of human immunodeficiency virus associated nephropathy at San Francisco General Hospital. Am J Kidney Dis 18:655-659, 1991
18. 18. Seney FD Jr, Burns DK, Silva FG: Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 16:1-13, 1990
19. 19. Cantor ES, Kimmel PL, Bosch JP: Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151:125-128, 1991
20. 20. Marques LP, Rioja LS, De Oliveria CA, Lopes GS, Santos OR: Kidney and HIV-infection. (letter) Clin Nephrol 37:269-270, 1992
21. 21. Lopes GS, Marques LP, Rioja LS, Basilio De Oliveira CA, Oliveira AV, Nery AC, Santos OR: Glomerular disease and human immunodeficiency virus infection in Brazil. Am J Nephrol 12:281-287, 1992
22. 22. Rao TK, Friedman EA: Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome. Am J Kidney Dis 25:390-398, 1995
23. 23. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G: Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35:1358-1370, 1989
24. 24. D'Agati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 8:138-152, 1997
25. 25. D'Agati V, Appel GB: Renal pathology of human immunodeficiency virus infection. Semin Nephrol 18:406-421, 1998
26. 26. Chander P, Soni A, Suri A, Bhagwat R, Yoo J, Treser G: Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 126:513-526, 1987
27. 27. Pardo V, Aldana M, Colton RM, Fischl Ma, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101:429-434, 1984
28. 28. Pardo V, Meneses R, Ossa L, Jaffe, DJ. Strauss J, Roth D, Bourgoignie JJ: AIDS-related glomerulopathy: Occurrence in specific risk groups. Kidney Int 31:1167-1173, 1087
29. 29. Cohen AH, Nast CC: HIV-associated nephropathy: A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1:87-97, 1988
30. 30. Glassock RJ, Cohen AH, Danovitch G, Parsa KP: Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med 112:35-49, 1990
31. 31. Humphreys MH: Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 48:311-320, 1995
32. 32. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310:669-673, 1984
33. 33. Rao TK, Friedman EA: Renal syndromes in the acquired immunodeficiency syndrome (AIDS): Lessons learned from analysis over 5 years. Artif Organs 12:206-209, 1988
34. 34. Bennett SJ, Rao TK, Friedman EA: Renal disease and the acquired immunodeficiency syndrome. (letter) Ann Intern Med 102:274-275, 1985
35. 35. Rao TK: Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 35S:13-18, 1991
36. 36. Bourgoignie JJ, Pardo V: The nephropathy in human immunodeficiency virus (HIV-1) infection. Kidney Int 40(Suppl 35):S19-S23, 1991
37. 37. Mokrzycki MH, Oo TN, Patel K, Chang CJ: Human immunodeficiency virus-associated nephropathy in the Bronx: Low prevalence in a predominantly Hispanic population. Am J Nephrol 18:508-512, 1998
38. 38. Winston JA, Burns GC, Klotman PE: The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 18:373-377, 1998
39. 39. Winston J, Klotman ME, Klotman PE: HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55:1036-1040, 1999
40. 40. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerusclerosis: A clinicopathologic study. Kidney Int 50:1734-1746, 1996
41. 41. Kimmel PL, Phillips TM, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: Brief report: Idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 327:702-706, 1992
42. 42. Kimmel P, Phillips T, Ferreira-Centeno A, Farkas-Szallasi T, Abraham A, Garrett C: HIV-associated immune-mediated renal disease. Kidney Int 44:1327-1340, 1993
43. 43. Ifudu O, Mayers JD, Matthew JJ, Macey LJ, Brezsnyak W, Reydel C, Mcclendon E, Surgrue T, Rao T, Rao TK, Friedman EA: Uremic therapy in patients with end-stage renal disease and human immunodeficiency virus infection: Has the outcome changed in the 1990s? Am J Kidney Dis 29:549-552, 1997
44. 44. Burns GC, Paul SK, Toth IR, Sivak SL: Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8:1140-1146, 1997
45. 45. U.S. Renal Data System: USRDS: Annual Data Report. Bethesda, MD, National Institutes of Health, NIDDK, 1997
46. 46. Smith SR, Svetkey LP, Dennis VW: Racial differences in the incidence and progression of renal diseases. (editorial) Kidney Int 40:815-822, 1991
47. 47. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377, 1996
48. 48. Smith RW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, Oíbrien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression: Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277:959-965, 1997
49. 49. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS). Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279:389-393, 1998
50. 50. O'Brien SJ, Dean M: In search of AIDS-resistance genes. Sci Am 277:44-51, 1997
51. 51. Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ, Dean M: Kovel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet 61:1261-1267, 1997
52. 52. Bodi I, Abraham AA, Kimmel PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 26:286-291, 1995
53. 53. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Kloiman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100:84-92, 1997
54. 54. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins Al, Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89:1577-1581, 1992
55. 55. Kopp JB, Bruggeman LA, Klotman PE: Extracellular matrix gene expression in experimental glomerulonephritis. Curr Opin Nephrol Hypertens 2:609-617, 1993
56. 56. Schwartz EJ, Klotman PE: Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 18: 436-445, 1998
57. 57. Daar ES, Moudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324:961-994, 1991
58. 58. Ho DD: HIV-1 dynamics in vivo. J Biol Regul Homeost Agents 9:76-77, 1995
59. 59. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271:1581-1586, 1996
60. 60. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD: Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279:1223-1227, 1998
61. 61. Pantaleo G, Graziosi C, Fauci AS: New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327-335, 1993
62. 62. Ahsan N, Langhoff E: Immunopathogenesis of human immunodeficiency virus. Semin Nephrol 18:422-435, 1998
63. 63. Bodi I, Kimmel PL, Abraham AA, Svetkey LP, Klotman PE, Kopp JB: Renal TGF-beta in HIV-associated kidney diseases. Kidney Int 51:1568-1577, 1997
64. 64. Ray PE, Bruggeman LA, Weeks BS, Kopp JB, Bryant J, Owens JW, Notkins AL, Klotman PE: bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy. Kidney Int 46:759-772, 1994
65. 65. Cohen A, Sun N, Shapshak P, Imagawa D: Demonstration of human immunodeficiency virus in renal epithelium of HIV-associated nephropathy. Mod Pathol 2:125-128, 1989
66. 66. Kimmel PL, Ferreira-Centeno A, Farkas Szallasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 43:1347-1352, 1993
67. 67. Green DF, Resnick L, Bourgoignie JJ: HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int41:956-960, 1992
68. 68. Alpers CE, Mcclure J, Bursten SL: Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am J Kidney Dis 19:126-130, 1992
69. 69. Ray PE, Liu XH, Henry D, Dye L, Xu L, Orenstein J, Schuztbank TE: Infection of human primary renal epithelial cells with HIV-I from children with HIV-associated nephropathy. Kidney Int 53:1217-1229, 1998
70. 70. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A: HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and fas upregulation. J Clin Invest 102:2041-2049, 1998
71. 71. Kimmel PL, Bosch JP, Vassalotti JA: Treatment of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 18:446-458, 1998
72. 72. Smith MC, Austen JL, Carey JT, Emancipator SN, Herbener T, Gripshover B, Mbanefo C, Phinney M, Rahman M, Salata RA, Weigel K, Kalayjian RC: Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101:41-48, 1996
73. 73. Smith MC, Pawar R, Carey JT, Graham RC Jr, Jacobs GH, Menon A, Salata RA, Seliga R, Kalayjian RC: Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy. Am J Med 97:145-151, 1994
74. 74. Kimmel PL, Mishkin GJ, Umana WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28:202-208, 1996
75. 75. Burns GC, Matute R, Onyema D, Davis I, Toth I: Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: A case report. Am J Kidney Dis 23:441-443, 1994
76. 76. Berger EA, Doms RW, Fenyo EM, Korber BT, Littman DR, Moore JP, Sattentau QJ, Schuttemaker H, Sodroski J, Weiss RA: A new classification for HIV-I. (letter) Nature 391:240, 1998
77. 77. Kimmel PL: Renal disease in HIV-infected patients: Pathogenesis, diagnosis, and treatment. AIDS Patient Care STDs 10:342-348, 1996
78. 78. Rubbert A, Combadiere C, Ostrowski M, Arthos J, Dybul M, Machado E, Cohn Ma, Hoxie JA, Murphy PM, Fauci AS, Weissman D: Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol 160:3933-3941, 1998
79. 79. Bandres JC, Wang QF, O'Leary J, Baleaux F, Amara A, Hoxie JA, Zolla-Pazner S, Gorny MK: Human immunodeficiency virus (HIV) envelope hinds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J Virol 72:2500-2504, 1998
80. 80. Endres MJ, Clapham PR, March M, Ahuja M, Turner JD, Mcknight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TN, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA: CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756, 1996
81. 81. Eitner F, Cui Y, Hudkins KL, Anderson DM, Schmidt A, Morton WR, Alpers CE: Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int 54:1945-1954, 1998
82. 82. Liu X-H, Hadley TJ, Xu L, Peiper SC, Ray PE: Upregulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 55:1491-1500, 1999
83. 83. Sanger R, Race RR, Jack JA: The Duffy blood groups of New York Negroes: The phenotype Fy (ab). Br J Haematol 163:253-258, 1995
84. + exchange in astrocytes. J Biol Chem 269:13811-13816, 1994
85. 85. Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, Chaikin MA, Shaw GM, Benveniste EN: Envelope glycoprotein gp120 of human immunodeficiency virus type I alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc Natl Acad Sci USA 91:494-498, 1994
86. + exchanger activity. Am J Physiol 253:C633-C638, 1987